Two SHMT2 isoforms were identified in ovarian cancer tissues, the smaller isoform was upregulated, even though downregulation of total SHMT2 in cisplatin-resistant tissues (Fig. 1B). The gene discussed is SHMT2; the disease is ovarian cancer.